What does CUSIP 00972D105 represent in this 13F holders report?

CUSIP 00972D105 is the security identifier for AKBA - Akebia Therapeutics, Inc. - Common Stock used to aggregate holder disclosures.

How many institutions held AKBA - Akebia Therapeutics, Inc. - Common Stock in Q2 2018?

136 institutional investors reported AKBA - Akebia Therapeutics, Inc. - Common Stock for Q2 2018. Use the holders table for investor-level position and value details.

Akebia Therapeutics, Inc. - Common Stock (AKBA)

CUSIP: 00972D105

Q2 2018 13F Holders as of 30 Jun 2018

Type / Class: Equity / Common Stock
Shares outstanding: 263,222,327
Total 13F shares: 42,400,943
Share change: -730,323
Total reported value: $423,114,024
Put/Call ratio: 4.8%
Price per share: $9.98
Number of holders: 136
Value change: -$5,780,444
Number of buys: 70
Number of sells: 63

Quarterly Holders Quick Answers

What is CUSIP 00972D105?
CUSIP 00972D105 identifies AKBA - Akebia Therapeutics, Inc. - Common Stock in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2018
Previous quarter: Q1 2018

Recent filing periods for CUSIP 00972D105:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AKBA - Akebia Therapeutics, Inc. - Common Stock (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
BlackRock Finance, Inc.	13F	Company	1.6%	4,297,707	$40,958,000	—	31 Mar 2018	13F
Nantahala Capital Management, LLC	13F	Company	1.3%	3,386,143	$32,270,000	—	31 Mar 2018	13F
Novo Holdings A/S	13F	Company	1.2%	3,100,000	$29,543,000	—	31 Mar 2018	13F
EAGLE ASSET MANAGEMENT INC	13F	Company	1%	2,725,571	$25,974,000	—	31 Mar 2018	13F
RENAISSANCE TECHNOLOGIES LLC	13F	Company	0.96%	2,519,100	$24,007,000	—	31 Mar 2018	13F
PERCEPTIVE ADVISORS LLC	13F	Company	0.94%	2,462,400	$23,467,000	—	31 Mar 2018	13F
VANGUARD GROUP INC	13F	Company	0.9%	2,359,189	$22,482,000	—	31 Mar 2018	13F
CARILLON TOWER ADVISERS, INC.	13F	Company	0.78%	2,060,804	$20,319,000	—	31 Mar 2018	13F
STATE STREET CORP	13F	Company	0.57%	1,500,213	$14,297,000	—	31 Mar 2018	13F
EcoR1 Capital, LLC	13F	Company	0.54%	1,425,000	$13,580,000	—	31 Mar 2018	13F
MORGAN STANLEY	13F	Company	0.45%	1,173,863	$11,186,000	—	31 Mar 2018	13F
Laurion Capital Management LP	13F	Company	0.37%	962,298	$9,171,000	—	31 Mar 2018	13F
FMR LLC	13F	Company	0.31%	814,155	$7,759,000	—	31 Mar 2018	13F
GOLDMAN SACHS GROUP INC	13F	Company	0.3%	781,457	$7,448,000	—	31 Mar 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.25%	658,022	$6,271,000	—	31 Mar 2018	13F
WELLINGTON MANAGEMENT GROUP LLP	13F	Company	0.24%	643,084	$6,128,000	—	31 Mar 2018	13F
DAFNA Capital Management LLC	13F	Company	0.23%	610,738	$5,820,000	—	31 Mar 2018	13F
Marshall Wace North America L.P.	13F	Company	0.23%	598,287	$5,702,000	—	31 Mar 2018	13F
FIRST MANHATTAN CO. LLC.	13F	Company	0.21%	565,066	$5,385,000	—	31 Mar 2018	13F
GEODE CAPITAL MANAGEMENT, LLC	13F	Company	0.21%	550,235	$5,242,000	—	31 Mar 2018	13F
NORTHERN TRUST CORP	13F	Company	0.2%	518,839	$4,944,000	—	31 Mar 2018	13F
AMERICAN CENTURY COMPANIES INC	13F	Company	0.19%	500,971	$4,774,000	—	31 Mar 2018	13F
Artal Group S.A.	13F	Company	0.18%	475,000	$4,527,000	—	31 Mar 2018	13F
DEUTSCHE BANK AG\	13F	Company	0.18%	461,445	$4,396,000	—	31 Mar 2018	13F
CHARLES SCHWAB INVESTMENT MANAGEMENT INC	13F	Company	0.13%	346,121	$3,299,000	—	31 Mar 2018	13F
CVI Holdings, LLC	13F	Company	0.12%	327,457	$3,121,000	—	31 Mar 2018	13F
Stanley-Laman Group, Ltd.	13F	Company	0.12%	314,401	$2,996,000	—	31 Mar 2018	13F
PNC FINANCIAL SERVICES GROUP, INC.	13F	Company	0.12%	313,848	$2,991,000	—	31 Mar 2018	13F
Spark Investment Management LLC	13F	Company	0.11%	302,100	$2,879,000	—	31 Mar 2018	13F
ACADIAN ASSET MANAGEMENT LLC	13F	Company	0.11%	300,432	$2,863,000	—	31 Mar 2018	13F
JPMORGAN CHASE & CO	13F	Company	0.1%	271,673	$2,589,000	—	31 Mar 2018	13F
BANK OF AMERICA CORP /DE/	13F	Company	0.1%	260,759	$2,485,000	—	31 Mar 2018	13F
MARSHALL WACE, LLP	13F	Company	0.09%	234,769	$2,237,000	—	31 Mar 2018	13F
CITADEL ADVISORS LLC	13F	Company	0.09%	229,314	$2,186,000	—	31 Mar 2018	13F
TIAA CREF INVESTMENT MANAGEMENT LLC	13F	Company	0.08%	220,269	$2,099,000	—	31 Mar 2018	13F
NORGES BANK	13F	Company	0.08%	207,173	$1,974,000	—	31 Mar 2018	13F
Man Group plc	13F	Company	0.08%	201,419	$1,920,000	—	31 Mar 2018	13F
Bank of New York Mellon Corp	13F	Company	0.08%	200,631	$1,911,000	—	31 Mar 2018	13F
Point72 Asset Management, L.P.	13F	Company	0.07%	194,150	$1,850,000	—	31 Mar 2018	13F
UBS Group AG	13F	Company	0.07%	192,349	$1,833,000	—	31 Mar 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.06%	147,110	$1,402,000	—	31 Mar 2018	13F
Alambic Investment Management, L.P.	13F	Company	0.05%	140,600	$1,340,000	—	31 Mar 2018	13F
MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC	13F	Company	0.05%	133,929	$1,276,000	—	31 Mar 2018	13F
Tekla Capital Management LLC	13F	Company	0.05%	132,849	$1,266,000	—	31 Mar 2018	13F
PANAGORA ASSET MANAGEMENT INC	13F	Company	0.05%	130,574	$1,244,000	—	31 Mar 2018	13F
Allianz Asset Management GmbH	13F	Company	0.05%	124,618	$1,188,000	—	31 Mar 2018	13F
LANDSCAPE CAPITAL MANAGEMENT, L.L.C.	13F	Company	0.04%	116,416	$1,109,000	—	31 Mar 2018	13F
HBK INVESTMENTS L P	13F	Company	0.04%	115,000	$1,096,000	—	31 Mar 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0.04%	114,178	$1,088,000	—	31 Mar 2018	13F
Alyeska Investment Group, L.P.	13F	Company	0.04%	102,435	$976,000	—	31 Mar 2018	13F

Institutional Holders of Akebia Therapeutics, Inc. - Common Stock (AKBA) as of Q2 2018

As of 30 Jun 2018, Akebia Therapeutics, Inc. - Common Stock (AKBA) was held by 136 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 42,400,943 shares. The largest 10 holders included BlackRock Inc., Nantahala Capital Management, LLC, Novo Holdings A/S, EAGLE ASSET MANAGEMENT INC, VANGUARD GROUP INC, PERCEPTIVE ADVISORS LLC, CARILLON TOWER ADVISERS, INC., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, and MORGAN STANLEY. This page lists 136 institutional shareholders reporting positions in this security for the Q2 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2018 vs Q1 2018 Across Filers

Q1 2018 holders

144

Q2 2018 holders

136

Holder diff

-8

Investor	Q1 2018 Shares	Q2 2018 Shares	Share Diff	Share Chg %	Q1 2018 Value $	Q2 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.